Navigation Links
Okyanos Heart Institute’s Chief Medical Officer Speaks at ACC’s Scientific Session
Date:2/28/2013

FREEPORT, The Bahamas (PRWEB) February 28, 2013

Okyanos Heart Institute, which brings a new standard of care and better quality of life to patients with chronic coronary artery disease using cardiac stem cell therapy, announces that Chief Medical Officer Howard Walpole Jr., M.D., MBA, FACC, FACAI will speak at The American College of Cardiology’s (ACC’s) 13th Annual Scientific Session. Dr. Walpole will join a panel of experts on the topic of “Readmission Reduction: Why Should You Care?” The session features thought leaders who will provide the latest data on successful readmission strategies. They will incorporate case studies and results from Medicare's recent test project, and an emphasis on care coordination with a proven track record in reducing readmissions in three index conditions: heart failure, acute myocardial infarction, and pneumonia. The session will be held from 12:30 p.m. to 1:45 p.m. on Sunday, March 10 at the Moscone Center in San Francisco.

“Readmissions for the three index conditions account for over $17 billion a year (in 2004) in health care expenses,” said Cathleen Biga, chief executive officer of Cardiovascular Management of Illinois (CMI) and the chair of the session. “Hospitals readmit nearly one in five Medicare patients within one month of discharge. Since October 1, 2012, over 2,200 hospitals are facing penalties (payment adjustments) totaling over $280 million, making this topic one of the most important, if not the most important topic of 2013.”

“I am looking forward to bringing this important discussion to the ACC conference,” said Walpole. “My topic in the discussion will be about reducing heart failure readmissions using a case study method to help participants through this transformative area of healthcare.”

More information about the event can be found at http://www.cardiosource.org/acc

ABOUT OKYANOS HEART INSTITUTE:
Based in Freeport, The Bahamas, Okyanos Heart Institute adheres to U.S. surgical center standards and is led by Chief Medical Officer Howard T. Walpole Jr., M.D., MBA, FACC, FACAI, and a leader of the American College of Cardiology for many years. The mission of Okyanos Heart Institute is to bring a new standard of care and a better quality of life to patients with chronic coronary artery disease using cardiac stem cell therapy. Okyanos Treatment utilizes cardiac stem cell therapy, a unique blend of stem and regenerative cells to support the growth of new blood vessels and to assist the heart in repairing tissue damaged by heart attack and disease. The Greek god of rivers, “Okyanos” symbolizes the primary mechanism of action that these adult stem cells have on ischemic (lack of blood flow) heart tissue, the result of the plaque deposits in the coronary arteries. The stem cells, derived from a person’s adipose (fat) tissue, create new blood vessels, a process known as angiogenesis. The treatment helps to facilitate blood flow in the heart and intake and use of oxygen, as measured by a rigorous clinical trial known as the PRECISE trial, as well as cardiac cell therapy trials at leading research institutions. For more information, log on to http://www.okyanos.com/.

Read the full story at http://www.prweb.com/releases/2013/2/prweb10455207.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. Okyanos Heart Institute’s Chief Medical Officer To Speak At American College Of Cardiology Seminar In Florida
2. Witnessing, Experiencing Traumatic Events May Worsen Heart Disease
3. Risk of suicide and fatal heart attack immediately following a cancer diagnosis
4. Cancer Diagnosis May Raise Odds for Suicide, Heart Attack Death
5. In children born with severe heart defect, surgical management has little effect on neuro outcomes
6. Invasive heart test being dramatically overused, Stanford study shows
7. Heart failure patients with diabetes may benefit from higher glucose levels
8. Omega-3 Supplements No Help Against Repeat Heart Trouble: Review
9. EKG Heart Test May Predict Risk in Older Adults
10. Common Blood Pressure Drug Safe for Heart Failure: Study
11. Spouses of Cancer Patients May Have Raised Risk of Heart Disease, Stroke
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/13/2016)... ... ... With FCPX Overlay Embers from Pixel Film Studios users can now apply ... user can select from up to 40 effect overlays. With FCPX Overlay Embers users ... value, contrast, glow, and more all within a click of a mouse. , ...
(Date:2/13/2016)... ... , ... When an Au Pair comes all the way around the world to ... and they are often worried things won’t go well. More often than not, however, they ... Pair of the Year winner’s all commented how their Au Pairs have become a part ...
(Date:2/12/2016)... ... February 12, 2016 , ... Mystic Buddha Publishing House presents Valentine’s ... Buddha, the biography of Rama - Dr. Frederick Lenz. , According to ... of a Buddhist teacher for teaching and helping others. Valentine’s Day celebrates love ...
(Date:2/12/2016)... ... ... , Back to the Future , Feb. 25, 2016 — 11:00 a.m. – 12:30 p.m. ... learn from history are doomed to repeat it.” , An analysis of CDRH’s enforcement actions ... takes time. , Take a close look at the warning letters the agency sent ...
(Date:2/12/2016)... ... ... Coco Libre, the maker of coconut water beverages with a purpose, is ... Coco Libre will offer musicians and celebrities the company’s signature Organic Coconut Water, a ... suite, held this year at the W Hollywood Hotel, has become a pre-show “must” ...
Breaking Medicine News(10 mins):
(Date:2/12/2016)... -- Memorial Hermann Health System has teamed up with Houston ... a one-of-a-kind experience to pediatric patients at Children,s ... 360-degree video and Google Cardboard, Howard was able to ... the patients and their families an unexpected, and energetically ... video . Memorial Hermann IRONMAN Sports ...
(Date:2/12/2016)... 12, 2016  Aralez Pharmaceuticals Inc. (Nasdaq: ARLZ ... Company will ring the Nasdaq Closing Bell at the ... at 4:00 p.m. ET on Tuesday, February ... Adrian Adams , will perform the honorary ... 4:00 p.m. ET.  A live webcast will be available ...
(Date:2/12/2016)... 12, 2016 --> ... Chronic Inflammation Global Clinical Trials Review, H2, 2015 ... global clinical trials landscape along with top level ... Country (G7 & E7), Trial Status, Trial Phase, ... top companies involved and enlists all trials (Trial ...
Breaking Medicine Technology: